Ensign Peak Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Buy |
858,834
+360,100
| +72% | +$5.33M | 0.02% | 416 |
|
|
2025
Q1 | $8.94M | Buy |
+498,734
| New | +$8.94M | 0.02% | 493 |
|
|
2023
Q3 | – | Sell |
-110,088
| Closed | -$1.69M | – | 1765 |
|
|
2023
Q2 | $1.69M | Hold |
110,088
| – | – | ﹤0.01% | 941 |
|
|
2023
Q1 | $2.48M | Buy |
110,088
+32,858
| +43% | +$739K | 0.01% | 755 |
|
|
2022
Q4 | $1.62M | Sell |
77,230
-20,100
| -21% | -$423K | ﹤0.01% | 893 |
|
|
2022
Q3 | $2.4M | Buy |
97,330
+20,431
| +27% | +$503K | 0.01% | 720 |
|
|
2022
Q2 | $1.86M | Buy |
76,899
+65,819
| +594% | +$1.59M | ﹤0.01% | 829 |
|
|
2022
Q1 | $286K | Buy |
+11,080
| New | +$286K | ﹤0.01% | 1770 |
|